Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
12.98
-0.70 (-5.12%)
Mar 31, 2025, 1:31 PM EDT - Market open
Dynavax Technologies Employees
Dynavax Technologies had 405 employees as of December 31, 2024. The number of employees decreased by 3 or -0.74% compared to the previous year.
Employees
405
Change (1Y)
-3
Growth (1Y)
-0.74%
Revenue / Employee
$684,558
Profits / Employee
$67,430
Market Cap
1.61B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DVAX News
- 21 days ago - Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors - Business Wire
- 25 days ago - Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase - PRNewsWire
- 27 days ago - Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share - Seeking Alpha
- 4 weeks ago - Dynavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance - PRNewsWire
- 5 weeks ago - Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy - PRNewsWire
- 5 weeks ago - Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting - Business Wire